Thu, December 20, 2018
Wed, December 19, 2018
Tue, December 18, 2018
Mon, December 17, 2018
Fri, December 14, 2018

Matt Miksic Initiated (ABT) at Buy and Held Target at $82 on, Dec 18th, 2018

Matt Miksic of Credit Suisse, Initiated "Abbott Laboratories" (ABT) at Buy and Held Target at $82 on, Dec 18th, 2018.

Matt has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matt


  • David Lewis of "Morgan Stanley" Maintained at Buy with Increased Target to $82 on, Tuesday, December 4th, 2018
  • Isaac Ro of "Goldman Sachs" Upgraded from Hold to Strong Buy and Increased Target to $81 on, Friday, November 30th, 2018
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $79 on, Thursday, October 18th, 2018
  • Matthew Taylor of "Barclays" Initiated at Buy and Held Target at $80 on, Tuesday, October 16th, 2018
  • Robbie Marcus of "JP Morgan" Maintained at Buy with Increased Target to $81 on, Monday, October 8th, 2018
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $80 on, Monday, September 24th, 2018